This purposeful interaction amongst the serotoninergic and central dopaminergic techniques has been demonstrated in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic outcomes of psilocybin [5].Psyence was among the list of initially to develop and operate a federally licensed industrial psilocybin cultivatio